AFPHM resources

Hear from AFPHM Fellows and public health medicine experts on topics from training and professional practice to issues impacting us today.


Exam Preparation Series | October 2021 exam | March 2021 exam
National Training Days Series | 2021 | 2020
Webinars | Training program


October 2021 Exam Preparation

Session 1 Meet the lead examiner | 11 August 2021
Hosted by A/Prof Apo Demirkol (audio only)


Session 2 Health Promotion | 18 August 2021
Hosted by Dr Marisa Gilles and Dr Gregory Stewart (audio only)

Questions

Question 1
You are a public health physician working in a state health department. The prevalence of tobacco smoking in the non-Indigenous population is 15%, but in the Indigenous population is over 70%. Your director has asked you to develop a smoking cessation program targeting the Indigenous population in the state.

Outline the steps in developing this program.

Question 2
You are a public health physician working in the federal Department of Health. The recently released report from the Intergovernmental Panel on Climate Change (IPCC) on land management notes that the world must turn towards healthy plant-based diets to curb climate change. You have been asked to develop a health promotion program encouraging people to eat less meat and more vegetables.

Outline how you would develop your program.



Session 3 Communicable Disease | 1 September 2021
Hosted by Dr Douglas Shaw (SA) and Dr Gregory Stewart (NSW) (audio only)

Questions

Question 1 - Gastroenteritis Outbreak in a Hospital Ward
You are the on-duty public health physician in a primarily urban Public Health Unit. You have been rung by the infection control practitioner (ICP) from the nearby general hospital to say they appear to have an outbreak of vomiting and diarrhoea in one of their general medical wards with, to date, six inpatients and two staff unwell with symptoms, all with onset in the last 48 hours.

Outline the steps in developing this program.

Question 2 - Introduction of RSV Vaccine to National Immunisation Program
The Commonwealth government has just announced funding under the National Immunisation Program for a childhood RSV (respiratory syncytial virus) vaccine to be introduced in 12 months’ time. You have been asked by the Director of the Communicable Disease Control Branch to plan for the introduction of this new vaccine.

Outline how you would develop your program.



Session 4 Environmental Health | 15 September 2021
Hosted by Dr Richard Broome (NSW) and Dr Gregory Stewart (NSW) (audio only)

Questions

Question 1

You are the Director of Public Health at a regional public health unit. The local fire and rescue services requests that you join a multiagency group coordinating the response to and recovery from a large, high energy fire involving peanuts at a bird food factory. The group involves the fire and rescue service, the EPA, the local government authority and the police. A specific concern about this fire is that laboratory studies indicate that peanut allergen is not deactivated by high temperatures. The factory is on an industrial estate with a residential area approximately 200m south, in the direction of the initial plume. Police have issued a shelter-in-place message, although the plume is buoyant and dispersing effectively. The fire was brought under control in 48hrs, but it was then decided that a “controlled burn” technique would be used to extinguish the fire, meaning it was likely to continue for another 2 or 3 weeks. During this time, fire water containing peanut oil and other contaminants would be recycled through a local pond. 

Describe how you and your team will contribute to the multiagency response and recovery to this incident? 

Question 2

You are public health physician at a state health department. The state experiencing a severe mouse plague in rural areas. A Director of Public Health from an affected region contacts you for advice. They have received separate notifications from two different local hospital about individuals presenting unwell following domestic use of a rodenticide containing zinc phosphide. Zinc phosphide is licensed for agricultural use only and releases phosphine when exposed to moisture. The Director of Public Health reports that, anecdotally, people are resorting to off-label use of zinc phosphide because of a shortage of rodenticides approved for domestic use. 

What advice would you give and how would you assist?

 


March 2021 Exam Preparation

Session 1 Meet the lead examiner | 13 January 2021
Hosted by Dr Margaret Young and Dr Greg Stewart (audio only)


Session 2 Health promotion / Aboriginal and Torres Strait Islander | 20 January 2021
Hosted by Dr Marissa Gilles (audio only)

Questions

Aboriginal and Torres Strait Islander question 1
You are the line manager for a team comprising mostly public health nurses and health promotion officers in a regional public health unit where the population demographics include three isolated Aboriginal nation clans each with estimated populations of about 1500. In the middle of an annual immunisation campaign that requires your staff to give immunisations directly to these Aboriginal communities, an elder from one of the nation clans calls you in a very agitated state telling you that one of your nurses has immunised an entire family for the second time in this campaign. This elder tells you that this nurse made very racist comments, did not believe the parents of the family that all the children had been immunised already that season, and had very rudely said that even if this was the case having a second flu shot would be okay because of the family’s 'living conditions'.

How do you respond immediately during the elder’s call?

What next steps will you prioritise in your investigations as the line manager and how would you resolve this complaint?

Health promotion question 1
You are a public health physician working in a state health department. The prevalence of tobacco smoking in the non-Indigenous population is 15%, but in the Indigenous population is over 70%. Your director has asked you to develop a smoking cessation program targeting the Indigenous population in the state.



Session 3 Communicable diseases | 3 February 2021
Hosted by Dr Douglas Shaw (audio only)

Questions

Question 1: Cryptosporidium outbreak
You are a public health physician working in your state/territory health department. You have been asked to take over the management of an outbreak of Cryptosporidium gastroenteritis thought to be linked to public swimming pools. The graph below describes Cryptosporidium notifications to date in your jurisdiction (first 10 weeks of 2020) and notifications for the equivalent periods in 2018 and 2019, by week of onset. It is now the start of week 11 in 2020.

Detail your approach, including the steps you will take in managing this outbreak?

Cryptospordiosis-notifications

Question 2: Two Hepatitis B cases
Your Public Health Unit has just identified two incident cases of hepatitis B in persons who have received renal dialysis. Initial enquiries confirm that both cases received dialysis at the same renal dialysis unit on a number of occasions in the last six months.

You have been asked to lead the investigation of this incident.

Describe the steps you would follow in investigating this incident and what outcome(s) you would be seeking to achieve.



Session 4 Environmental health | 10 February 2021
Hosted by Dr Vicky Sheppeard and Dr Greg Stewart (audio only)

Questions

Question 1
You are working in a metropolitan public health unit. Several large bushfires are burning around your district and have begun to encroach on residential areas. High winds in the direction of the metropolitan centre are predicted and you’ve just been notified that several thousand people are about to be advised to evacuate within the next 4 hours. A list of community centres and halls in safe areas will be provided to them. Outline what you would do over the next hours and days.

  1. What are the three main areas of public health response in this situation?
  2. Explain how you would investigate this issue

Question 2
You are a public health physician working in the Environmental Health Branch (EHB) of the State Health Department. The Government has just confirmed a plan to remediate a legacy contaminated site and use the land for a large new residential development. Existing residents adjacent to the site have commenced campaigning for the project to be abandoned and the land left untouched. They have cited overseas evidence of the risks of remediation and have concerns that both the remediation and new residents will increase traffic congestion.

The Health Minister has made a commitment to the local community that a “Health Study” will be undertaken. The Chief Health Officer (CHO) and the Director of EHB have asked you to rapidly prepare a brief to allow the Minister to make a decision about the form of the Health Study. The brief needs to include reference to the Framework for Human Health Risk Assessment and some study options.

  1. What key information will you include in your brief? (70%)
  2. What study options are available? (30%)


Session 5 Epidemiology | 17 February 2021
Hosted by Dr Robert Hall and Dr Greg Stewart (audio only)

Questions

Question 1
You are working as a public health adviser in the Maternal and Child Health Unit of a State Health department. There has been a public campaign, initiated by a parents’ group, to include genetic susceptibility testing for Type 1 diabetes as part of the State’s Newborn Screening Program. You have been asked to prepare a paper that details the advantages and disadvantages of such a program. Your manager has asked you to focus on the following questions:

  • What are the merits of screening for susceptibility to Type 1 diabetes? (30%)
  • What issues need to be considered in the development, design and implementation of such a screening program? (70%)

Question 2
You are part of team that is investigating adverse health effects in miners of rare earths*. There is increasing demand for these elements for the manufacture of batteries and electronic components. However, there are concerns about the health effects on miners of these minerals. You have been asked to develop a research question (and a supporting paper) to investigate the possibility of an increased incidence of lung cancer in these miners.

  • What do you think would be an appropriate study design? What are the advantages and disadvantages of this kind of study? (50%)
  • What would be the exposure of interest, and how would you define and measure it? (15%)
  • What would be the outcome of interest, and how would you define and measure it? (15%)
  • What other issues would you need to consider? (20%)

* The rare earths are a group of 17 elements:

  • the lanthanides (cerium, dysprosium, erbium, europium, gadolinium, holmium, lanthanum, lutetium, neodymium, praseodymium, promethium, samarium, terbium, thulium, and ytterbium)
  • scandium and yttrium

These minerals are often found together with thorium and uranium



Session 6 Policy and Planning | 24 February 2021
Dr Greg Stewart

Questions

Question 1
In November 2020, your Chief Health Officer assigned you overall planning responsibility for the roll-out of the national COVID-19 vaccination program in your State. Phase 1a of the program (priority front-line health staff, quarantine and border workers, residents and staff of Aged Care facilities – 700,000 persons Australia-wide) commenced successfully this week, with Phase 1b (other HCWs, other critical emergency service workers, elderly adults >70 years, Aboriginal and Torres Strait islander people >55 years, younger adults with an underlying medical condition or disability – 6.1 million persons Australia-wide) to begin in 6-8 weeks’ time.

  • Describe the process you used to develop the Phase 1 roll-out plan, and the key elements of the plan (60%)
  • What additional complexities will you need to address in Phase 1b (20%)
  • How will you monitor and evaluate the entire program? (20%)

Question 2
You have recently been appointed the Environmental Sustainability Lead for a large metropolitan health service. You are required to develop an Environmental Sustainability Plan for the health service.

  • How would you go about developing the Plan? (40%)
  • What are the key action areas that need to be included in the Plan? (40%)
  • How will you evaluate the plan (20%)


National Training Days Series | 2021

Session 1 Preparing for the AFPHM Oral Examination | 22 July 2021
Professor Michael Ackland and Dr Laksmi Govindasamy


Session 2 Health Promotion and Disease Prevention | 4 August 2021
Professor Julie Leask and Dr Nadia Chaves, chaired by Dr Frank Beard


Session 3 Policy Development | 24 August 2021
Professor Kate Conigrave and Dr Malcolm Dobbin, chaired by Dr Alyce Wilson



National Training Days Series | 2020

Session 1 AFPHM Oral Examination preparation | 5 November 2020
Professor Michael Ackland and Dr Miranda Harris discuss the AFPHM Oral Examination.


Session 2 Health promotion and community engagement | 19 November 2020
Professor Rob Moodie and Dr Leanne Coombes present on health promotion for non-communicable diseases, working in Indigenous health and promoting culturally safe practice in our future health workforce.


Session 3 Public health emergencies | 1 December 2020
Dr Ian Norton and Dr Vanessa Johnston speak about decision making under the pressure of COVID-19 and the public health impacts of poor air quality from bushfire smoke.


Webinars

Assessment of apparent cancer clusters | 27 July 2021
AFPHM monthly webinar presented by Professor Tim Driscoll | Presentation slide (PDF)


The climate crisis – prescription for action | June 29 2021
AFPHM monthly webinar presented by Dr Kate Charlesworth | Presentation Slide (PDF)


Measuring vaccine impact – principles and examples | 12 April 2021
AFPHM monthly webinar presented by Professor Peter McIntyre PHD, FRACP, FAFPHM | Presentation slide (PDF)


Yellow fever: Vaccination centres and providers | 10 February 2021
AFPHM monthly webinar presented by Professor Peter Leggat AM, ADC | Presentation slides (PDF)


Strengthening public health messages using mass media | 18 November 2020
AFPHM monthly webinar presented by Dr Becky Freeman


Training program

Welcome to the AFPHM Training Program | 17 March 2020
Faculty Education Committee Chair Dr Tony Gill provides a detailed overview of the Public Health Medicine Training Program for all trainees. Tony has a wealth of experience in supporting AFPHM trainees and offers insights into the finer details of the training program.


For more information on these resources contact us.
Close overlay